NASDAQ:SSKN Strata Skin Sciences (SSKN) Stock Price, News & Analysis $0.0001 0.00 (0.00%) As of 11/18/2026 03:14 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsInsider TradesNews and TrendsOwnershipSEC Filings About Strata Skin Sciences Stock (NASDAQ:SSKN) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Strata Skin Sciences alerts:Sign Up Key Stats Today's Range$0.0001▼$0.000150-Day Range N/A52-Week Range$0.00▼$1.53Volume284 shsAverage Volume167,780 shsMarket Capitalization$588.80P/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview STRATA Skin Sciences, Inc. is a medical technology company focused on developing and commercializing devices for the treatment of dermatological conditions. Its products are used by dermatologists and other healthcare providers in clinical settings. The company’s portfolio includes the XTRAC excimer laser and VTRAC excimer lamp, which deliver targeted ultraviolet light for conditions such as psoriasis and vitiligo. STRATA also offers the TheraClearX system, a device-based treatment for acne. STRATA was previously known as MELA Sciences and adopted its current name in 2016 as it shifted its focus toward dermatology treatment technologies. It serves customers in the United States and sells its products in international markets through distribution partners.AI Generated. May Contain Errors. Read More Strata Skin Sciences Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks2nd Percentile Overall ScoreSSKN MarketRank™: 0.108874281015 of 5 starsStrata Skin Sciences scored higher than 2% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.5 / 5Analyst RatingSell Consensus RatingStrata Skin Sciences has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageStrata Skin Sciences has received no research coverage in the past 90 days.Read more about Strata Skin Sciences' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Strata Skin Sciences are expected to grow in the coming year, from ($1.05) to ($1.04) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Strata Skin Sciences is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Strata Skin Sciences is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioStrata Skin Sciences has a P/B Ratio of 0.00. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Strata Skin Sciences' valuation and earnings. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for SSKN. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldStrata Skin Sciences does not currently pay a dividend.Dividend GrowthStrata Skin Sciences does not have a long track record of dividend growth. News and Social Media0.0 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Strata Skin Sciences this week, compared to 0 articles on an average week. Company Ownership1.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Strata Skin Sciences insiders have not sold or bought any company stock.Percentage Held by Insiders40.92% of the stock of Strata Skin Sciences is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions32.43% of the stock of Strata Skin Sciences is held by institutions.Read more about Strata Skin Sciences' insider trading history. Receive SSKN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Strata Skin Sciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SSKN Stock News HeadlinesStrata Skin Sciences (SSKN) Projected to Announce Earnings on TuesdayNovember 16 at 2:10 AM | americanbankingnews.comSTRATA Skin Sciences consensus price target increased by 45.95% to $11.02November 2, 2026 | msn.comI'm handing you this stock todayElon doesn't own the chip inside his Teslas or Starlink dishes. He licenses it from one little known public company. Now he's planning 1,000,000 AI satellites in orbit, and every one could pay this company a royalty. Analyst Dylan says the window to get in closes around December 8th, before new money floods into the buildout. | Behind the Markets (Ad)STRATA Skin Sciences Appoints Medical Device Commercial Leader Erica Jordan as Chief Executive OfficerJuly 28, 2026 | globenewswire.comNew Peer-Reviewed Publication Confirms Unprecedented Response Rates for STRATA's Excimer Laser Combined with JAK Inhibitors in Pediatric VitiligoMay 18, 2026 | globenewswire.comSTRATA Skin Sciences Confirms Nasdaq DelistingFebruary 19, 2026 | globenewswire.comSTRATA cites study supporting 308 nm laser for psoriasisFebruary 18, 2026 | msn.comJohns Hopkins Dermatology Expands Advanced Care for Inflammatory and Autoimmune Skin Conditions with Addition of XTRAC® Excimer LaserFebruary 18, 2026 | globenewswire.comSee More Headlines SSKN Stock Analysis - Frequently Asked Questions How have SSKN shares performed this year? Strata Skin Sciences' stock was trading at $1.26 at the start of the year. Since then, SSKN stock has decreased by 100.0% and is now trading at $0.0001. How were Strata Skin Sciences' earnings last quarter? Strata Skin Sciences, Inc. (NASDAQ:SSKN) announced its quarterly earnings results on Thursday, November, 13th. The medical device company reported ($0.36) EPS for the quarter, missing analysts' consensus estimates of ($0.24) by $0.12. The medical device company had revenue of $6.93 million for the quarter, compared to analyst estimates of $7.72 million. Strata Skin Sciences had a negative trailing twelve-month return on equity of 476.73% and a negative net margin of 35.64%. Read the conference call transcript. When did Strata Skin Sciences' stock split? Strata Skin Sciences's stock reverse split before market open on Friday, June 7th 2024.The 1-10 reverse split was announced on Friday, June 7th 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, June 7th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of Strata Skin Sciences? Shares of SSKN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Strata Skin Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Strata Skin Sciences investors own include Tesla (TSLA), GE Aerospace (GE), Ford Motor (F), Amarin (AMRN), Plug Power (PLUG), Advanced Micro Devices (AMD) and Gevo (GEVO). Company Calendar Today11/18/2026Next Earnings (Estimated)11/18/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (9m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 SSKN's financial health is in the Red zone, according to TradeSmith. SSKN has been in this zone for over 9 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:SSKN CIK1051514 Webwww.strataskinsciences.com Phone(215) 619-3200Fax215-619-3208Employees120Year Founded1989Profitability EPS (Trailing Twelve Months)($1.41) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$10.09 million Net Margins-35.64% Pretax Margin-36.34% Return on Equity-476.73% Return on Assets-33.49% Debt Debt-to-Equity Ratio10.22 Current Ratio0.95 Quick Ratio0.75 Sales & Book Value Annual Sales$30.98 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$1.19 per share Price / Book0.00Miscellaneous Outstanding Shares5,888,000Free Float3,479,000Market Cap$588.80 OptionableNot Optionable Beta0.33 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:SSKN) was last updated on 11/18/2026 by MarketBeat.com Staff. From Our PartnersYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredPentagon magnet restrictions take effect January 1, 2027A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It...OilPrice | SponsoredTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Tradi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | Sponsored432 miles southeast of Washington, DC…Spruce Pine, North Carolina, a town of just over 2,000 people, has supplied a material to every major chip mak...Wall Street Watchdogs | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Strata Skin Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Strata Skin Sciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.